The cost-effectiveness of sertraline in the treatment of depression

By Olvey Eleanor L   Skrepnek Grant H  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 14, 2008-10 ,pp. : 2497-2508

Informa Healthcare

Access to resources Recommend Favorite

Prevention of Recurrent Rhinopharyngitis in At-Risk Children in France: A Cost-Effectiveness Model for a Nonspecific Immunostimulating Bacterial Extract (OM-85 BV)

By Pessey J-J.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1053-1068

Adis International

Access to resources Recommend Favorite

Treatment of Recurrent Depression: An Alternate Viewpoint

By Thase M.E.  

CNS Drugs, Vol. 17, Iss. 15, 2003-01 ,pp. : 1119-1122

Adis International

Access to resources Recommend Favorite

Assessment of the Cost Effectiveness of Travoprost versus Latanoprost as Single Agents for Treatment of Glaucoma in France

By Payet Stéphanie  

Clinical Drug Investigation, Vol. 28, Iss. 3, 2008-01 ,pp. : 183-198

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria

By Guest J.F.   Abegunde D.   Ruiz F.J.  

Clinical Drug Investigation, Vol. 24, Iss. 6, 2004-01 ,pp. : 305-321

Adis International

Access to resources Recommend Favorite